These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 13410706)

  • 1. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].
    PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK
    Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood crasis, Mommsen granulations and leukocytic glycogen in diabetics treated with N'-sulfanilyl-N2-n-butyl urea].
    PELLEGRINI R; RUMPIANESI G
    Endocrinol Sci Cost; 1956; 23(4):272-8. PubMed ID: 13404963
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electrophoretic serous patterns (proteins, lipoproteins and glycoproteins) of diabetics during treatment with N-sulfanilyl-N'-butyl urea and N-tolyl-sulfonyl-N'-butyl urea].
    ZAMPA GA
    G Clin Med; 1957 Jan; 38(1):42-57. PubMed ID: 13448420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary excretion of acid mucopolysaccharides and mucoprotein in diabetics in basal conditions and after treatment with N-sulfanilyl-N'-butyl urea].
    GALLETTI F; PELLEGRINI R
    Arch Patol Clin Med; 1957; 33(3):153-64. PubMed ID: 13425840
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in glycemia and urea excretion in fasting diabetics treated with sulfanil-n-butyl urea].
    FEDELI S; MAGGI G; RIZZOLINI G
    Arch Sci Med (Torino); 1957 May; 103(5):361-7. PubMed ID: 13445444
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects butyl-sulfonyl urea on blood lipids in diabetics].
    CORSINI G; GUACCI L
    Minerva Med; 1957 Apr; 48(27):1119-24. PubMed ID: 13440686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical data in diabetics treated with sulfanil-n-butyl urea].
    TAMBUSCIO S; FALETRA G
    Arch Sci Med (Torino); 1957 May; 103(5):355-60. PubMed ID: 13445443
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.
    KERLAN M
    J Tn State Med Assoc; 1957 Feb; 50(2):46-8. PubMed ID: 13399061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of oral antidiabetic drugs on blood sugar & blood phosphate curves after oral & intravenous glucose administration].
    JENSEN SE; LUNDBAEK K; MOLLER B; RAFAELSEN OJ
    Ugeskr Laeger; 1957 Jun; 119(26):825-9. PubMed ID: 13455941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences concerning the effects of N-sulfanilyl-N'-butyl urea in diabetes mellitus].
    TOLOMELLI E; BACCI L
    Rass Clin Ter; 1957; 56(1):1-16. PubMed ID: 13441924
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoglycemic coma in diabetics treated with sulfabutyl urea (BZ 55)].
    BUTTARO CA; TRAMONTANA C; GUAITINI V
    Riforma Med; 1957 Apr; 71(16):441-2. PubMed ID: 13442477
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral management of diabetes mellitus with a sulfonyl-urea derivative, BZ 55].
    BERTRAM F
    Nord Med; 1956 Dec; 56(51):1834-7. PubMed ID: 13400309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of N-sulfanilyl-N' -butyl urea in normal and pancreatectomized dog].
    MIHICH E; PRINO G
    Farmaco Sci; 1956; 11(10):811-8. PubMed ID: 13414851
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatal encephalomyelitis after or because of N1-sulfanilyl-N2-n-butylcarbamide therapy of a diabetes case].
    BARTELHEIMER H
    Arztl Wochensch; 1957 Mar; 12(13):283-5. PubMed ID: 13410715
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ambulant therapy of diabetics with hypoglycemic sulfonamide (BZ 55, nadisan, invenol)].
    HOFSTETTER JR; RAMEL C
    Helv Med Acta; 1956 Nov; 23(4-5):485-9. PubMed ID: 13398003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver function in diabetics treated with N-sulfanilyl-N'-butyl urea].
    DI NOIA V; GALLETTI F; PELLEGRINI R
    Minerva Med; 1956 Sep; 47(73):613-4. PubMed ID: 13387155
    [No Abstract]   [Full Text] [Related]  

  • 19. [N1-sulfanyl N2-n-butylcarbamide (BZ 55) in the treatment of diabetes mellitus].
    TRAVERSO R; PATELLI R
    Friuli Med; 1956; 11(6, bis):1053-60. PubMed ID: 13438118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver function tests in diabetics with tuberculosis treated with N-sulfanilyl-N'-butyl urea].
    LUISETTI GL; ABBATE G; CORSITTO A
    Minerva Med; 1957 Feb; 48(13):538-43. PubMed ID: 13418528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.